The apparent permeabilities of Caco-2 cells to marketed drugs: magnitude, and independence from both biophysical properties and endogenite similarities
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The apparent permeabilities of Caco-2 cells to marketed drugs: magnitude, and independence from both biophysical properties and endogenite similarities
Authors
Keywords
-
Journal
PeerJ
Volume 3, Issue -, Pages e1405
Publisher
PeerJ
Online
2015-11-17
DOI
10.7717/peerj.1405
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Application of Caco-2 Cell Line in Herb-Drug Interaction Studies: Current Approaches and Challenges
- (2016) Charles Awortwe et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- A Global Map of Lipid-Binding Proteins and Their Ligandability in Cells
- (2015) Micah J. Niphakis et al. CELL
- A Call for Systematic Research on Solute Carriers
- (2015) Adrián César-Razquin et al. CELL
- Software review: the KNIME workflow environment and its applications in genetic programming and machine learning
- (2015) Steve O’Hagan et al. Genetic Programming and Evolvable Machines
- Direct In Vivo Human Intestinal Permeability (Peff) Determined with Different Clinical Perfusion and Intubation Methods
- (2015) David Dahlgren et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Engineered CRISPR-Cas9 nucleases with altered PAM specificities
- (2015) Benjamin P. Kleinstiver et al. NATURE
- Membrane transporter engineering in industrial biotechnology and whole cell biocatalysis
- (2015) Douglas B. Kell et al. TRENDS IN BIOTECHNOLOGY
- Quantifying the impact of transporters on cellular drug permeability
- (2015) Pär Matsson et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Fitting Transporter Activities to Cellular Drug Concentrations and Fluxes: Why the Bumblebee Can Fly
- (2015) Pedro Mendes et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- What would be the observable consequences if phospholipid bilayer diffusion of drugs into cells is negligible?
- (2015) Douglas B. Kell TRENDS IN PHARMACOLOGICAL SCIENCES
- Understanding the foundations of the structural similarities between marketed drugs and endogenous human metabolites
- (2015) Steve O'Hagan et al. Frontiers in Pharmacology
- Applications of a 7-day Caco-2 cell model in drug discovery and development
- (2014) Ying Peng et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- In vitroandin vivoapproaches to characterize transporter-mediated disposition in drug discovery
- (2014) Bo Feng et al. Expert Opinion on Drug Discovery
- A ‘rule of 0.5’ for the metabolite-likeness of approved pharmaceutical drugs
- (2014) Steve O′Hagan et al. Metabolomics
- High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells
- (2014) Yuexin Zhou et al. NATURE
- The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity
- (2014) Georg E Winter et al. Nature Chemical Biology
- What do drug transporters really do?
- (2014) Sanjay K. Nigam NATURE REVIEWS DRUG DISCOVERY
- How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion
- (2014) Douglas B. Kell et al. Frontiers in Pharmacology
- Membrane transporters in a human genome-scale metabolic knowledgebase and their implications for disease
- (2014) Swagatika Sahoo et al. Frontiers in Physiology
- KNIME-CDK: Workflow-driven cheminformatics
- (2013) Stephan Beisken et al. BMC BIOINFORMATICS
- Drug Discovery Applications for KNIME: An Open Source Data Mining Platform
- (2013) Michael P. Mazanetz et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery
- (2013) Douglas B. Kell et al. DRUG DISCOVERY TODAY
- Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it
- (2013) Douglas B. Kell FEBS Journal
- An analysis of a ‘community-driven’ reconstruction of the human metabolic network
- (2013) Neil Swainston et al. Metabolomics
- A community-driven global reconstruction of human metabolism
- (2013) Ines Thiele et al. NATURE BIOTECHNOLOGY
- CRISPR RNA–guided activation of endogenous human genes
- (2013) Morgan L Maeder et al. NATURE METHODS
- DrugBank 4.0: shedding new light on drug metabolism
- (2013) Vivian Law et al. NUCLEIC ACIDS RESEARCH
- Genetic Screens in Human Cells Using the CRISPR-Cas9 System
- (2013) Tim Wang et al. SCIENCE
- Open-source platform to benchmark fingerprints for ligand-based virtual screening
- (2013) Sereina Riniker et al. Journal of Cheminformatics
- Genome-wide assessment of the carriers involved in the cellular uptake of drugs: a model system in yeast
- (2012) Karin Lanthaler et al. BMC BIOLOGY
- The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so
- (2012) Douglas B. Kell et al. DRUG DISCOVERY TODAY
- Cell-basedin vitromodels for predicting drug permeability
- (2012) Bruno Sarmento et al. Expert Opinion on Drug Metabolism & Toxicology
- QSAR-based permeability model for drug-like compounds
- (2011) Rafael Gozalbes et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only
- (2011) Douglas B. Kell et al. DRUG DISCOVERY TODAY
- Drug-permeability and transporter assays in Caco-2 and MDCK cell lines
- (2011) Donna A Volpe Future Medicinal Chemistry
- KNIME Workflow to Assess PAINS Filters in SMARTS Format. Comparison of RDKit and Indigo Cheminformatics Libraries
- (2011) Simon Saubern et al. Molecular Informatics
- Extensive In Vivo Metabolite-Protein Interactions Revealed by Large-Scale Systematic Analyses
- (2010) Xiyan Li et al. CELL
- Recent advances in asymmetric oxidative coupling of 2-naphthol and its derivatives
- (2010) Hui Wang CHIRALITY
- Attenuation of Intestinal Absorption by Major Efflux Transporters: Quantitative Tools and Strategies Using a Caco-2 Model
- (2010) X. Lin et al. DRUG METABOLISM AND DISPOSITION
- Towards Prediction of In Vivo Intestinal Absorption Using a 96-Well Caco-2 Assay
- (2010) Suzanne Skolnik et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Implications of the Dominant Role of Transporters in Drug Uptake by Cells (Supplementary Material)
- (2009) Paul Dobson et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Conciliating binding efficiency and polypharmacology
- (2009) Jordi Mestres et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- ‘Metabolite-likeness’ as a criterion in the design and selection of pharmaceutical drug libraries
- (2008) Paul D. Dobson et al. DRUG DISCOVERY TODAY
- Transport of Dicationic Drugs Pentamidine and Furamidine by Human Organic Cation Transporters
- (2008) X. Ming et al. DRUG METABOLISM AND DISPOSITION
- Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories
- (2008) Rose Hayeshi et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The Caco-2 cell monolayer: usefulness and limitations
- (2008) Huadong Sun et al. Expert Opinion on Drug Metabolism & Toxicology
- Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
- (2008) Paul D. Dobson et al. NATURE REVIEWS DRUG DISCOVERY
- Array-based evolution of DNA aptamers allows modelling of an explicit sequence-fitness landscape
- (2008) Christopher G. Knight et al. NUCLEIC ACIDS RESEARCH
- A modified fast (4 day) 96-well plate Caco-2 permeability assay
- (2008) Masashi Uchida et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started